Sexually Transmitted Diseases Testing Market Size, Share and Global Trend By Disease (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papillomavirus, Human Immunodeficiency Virus, Chancroid, Others), By Location (Laboratory, Point of Care), By Device (Laboratory Devices, Point of Care (POC) Devices) and Geography Forecast till 2022-2029

Sexually transmitted diseases refer to the infections that are transmitted from one person to another during the various types of sexual intercourse. There are more than 20 types of sexually transmitted diseases which includes genital herpes, chlamydia, human immunodeficiency virus (HIV), gonorrhea, human papillomavirus, syphilis, trichomoniasis, and others. Antibiotics are often administered for the treatment of sexually transmitted diseases caused by bacteria, yeast, or parasites.

According to the World Health Organization, more than 1 million new cases of sexually transmitted diseases occur each day globally. If the individual already has a sexually transmitted disease (STD), it becomes easy for the individual to be infected by the human immunodeficiency virus (HIV).

To gain extensive insights into the market, Request for Customization

These trends and the increasing prevalence of sexually transmitted diseases (STDs) are anticipated to contribute to the global sexually transmitted diseases testing market growth. In April 2019, Quest Diagnostics announced the launch of three new testing kits for home care settings, which will further contribute to the growth of the market.

The rise in the prevalence of microbial infections such as chlamydia, gonorrhea, herpes simplex virus, syphilis, human papillomavirus (HPV), trichomonas vaginal and vaginitis are some of the significant factors aiding in the global sexually transmitted diseases testing market growth.

Additionally, initiatives taken by governmental organizations to spread awareness about the sexually transmitted diseases and high investment in the development of the faster detection systems are some of the factors driving the global sexually transmitted diseases testing market growth.

The high social stigma, high cost of the detection systems, and lack of accuracy are some of the factors restraining the global sexually transmitted diseases testing market growth.

Key Players Covered

The major companies covered in the global sexually transmitted diseases testing market report include F. Hoffmann-La Roche Ltd., Abbott, Becton, Dickinson, and Company (BD), Hologic Inc., Danaher, Quest Diagnostics, Thermo Fisher Scientific, bioMérieux SA, and others.

SEGMENTATION

As per the current sexually transmitted diseases testing market trends, chlamydia in the disease segment is expected to account for the highest market share in the global sexually transmitted diseases testing market because of its high prevalence and the status of the disease as the most commonly occurring sexually transmitted disease in the U.S.

Key Insights

• Regulatory scenario for key countries


• Pipeline analysis


• Technological advancements in sexually transmitted diseases devices


• Prevalence of sexually transmitted diseases by key countries


• PESTEL analysis


• Recent industry developments such as partnerships, mergers, and acquisitions


• Overview of new product launches in sexually transmitted diseases testing

Regional Analysis

North America and Europe accounted for the highest share in sexually transmitted diseases testing market in 2018. The prevalence of sexually transmitted diseases, presence of public healthcare insurance plans and availability of FDA-approved advanced sexually transmitted diseases testing devices in the region are some of the factors expected to project the growth of the sexually transmitted diseases in the North America region. Asia Pacific region is anticipated to grow at a significant CAGR over the forecast period, owing to the presence of high patient population, rising awareness for sexually transmitted infections (STIs), and increasing government initiatives and rising disposable income leading to the increase in healthcare expenditure levels. Increasing prevalence of kidney stones is anticipated to contribute to the growth of the Latin America and Middle East & Africa sexually transmitted diseases testing market in the future.

Sexually Transmitted Diseases Testing Industry Developments

• In April 2019, Quest Diagnostics announced the launch of three new test kits for the sexually transmitted diseases (STD) that the customers can order and can purchase directly online
• In November 2018, free online testing services for sexually transmitted diseases was launched by Sexual Health West Sussex